Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Status:
Recruiting
Trial end date:
2026-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether psilocybin, a hallucinogenic drug, is
effective in reducing depressive symptoms and amount of drinking in patients with
co-occurring Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD).